In this episode of the DeviceTalk Weekly podcast, Host Tom Salemi talks with MedTech legend Daniel Hawkins, a serial entrepreneur who has a hand in many industry success stories. He was employee number six at Intuitive before setting out on a path of innovation, developing the technologies around companies like Shockwave Medical.

More recently, Hawkins was CEO of Avail Medsystems, the presumed leader of the pack of companies trying to redefine OR communications, but that company shuttered last year when it couldn’t raise additional capital.

Today, Hawkins is leading Vista.ai, which is selling an AI-enabled package that makes it much easier for MRI technologists to capture meaningful images of the heart. Hawkins sees Vista.ai as improving patient care while also helping imaging centers address the crushing shortfall of experts.

This episode is sponsored by DeviceTalks Boston. Register to attend our April 30-May 1 event of the year at Boston.Devicetalks.com.

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss out on a future episode.

In this episode of the DeviceTalks Weekly Podcast, we get an inside look into why Boston Scientific’s AF Solutions division has experienced such a meteoric rise over the past few years. CMO Dr. Brad Sutton lays out the problem facing patients and physicians when treating atrial fibrillation and how acquisitions of pulsed-field ablation tool FARAPULSE is changing the game.

This episode is sponsored by Freudenberg Medical. To discuss a partnership with Freudenberg Medical for your EP catheter portfolio, please visit https://ep.freudenbergmedical.com/.

Chris Newmarker of MassDevice joins Host Tom Salemi in delivering this week’s Newmarker’s Newsmakers - Abbott, Boston Scientific, Intuitive, and Medtronic.

Thank you for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In this episode of the DeviceTalks Weekly Podcast, we’ll play the interview Host Tom Salemi conducted with Adam Elsesser, CEO of Penumbra, which has grown into a force in the vascular and neurovascular industries.

Elsesser’s path into running a MedTech startup was quite accidental, but that unorthodox path has helped the company develop a unique culture for innovation. Elsesser shares that philosophy in this interview and explains why he prefers uncertainty over risk.

Kicking off the episode Jim Hammerand, managing editor of Medical Design and Outsourcing, visits with Chris Newmarker and Salemi to share the highlights of the magazine’s leadership issue including an in-depth interview he did with former Edwards Lifesciences CEO Mike Mussallem.

The three then run through this week’s Newmarker’s Newsmakers - Integra, Olympus, Johnson & Johnson, Boston Scientific, Stryker, and Inari.

Go to DeviceTalks.com to register for our conferences and digital events.

Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In this episode of Neuro Innovation Talks, host John Murray interviews Charles "Chuck" Kerber, MD, Emeritus Professor of Radiology and Neurosurgery at UCSD, a pioneering force in neurovascular medicine, whose innovations—such as flow-directed catheters and cyanoacrylates for therapeutic embolization—transformed the field. Dr. Kerber reflects on his Appalachian roots and military experience, highlighting how these influences shaped his views on responsibility, mentorship, and patient-centered care. His philosophy of innovation, grounded in imagination and resilience, offers a blueprint for tackling complex medical challenges.

The discussion explores the iterative process of developing life-saving neurovascular devices, from early failures to groundbreaking successes, and emphasizes the vital role of collaboration with industry partners. Dr. Kerber shares stories of his mentorship style, which encouraged creativity and accountability, and its profound impact on the next generation of neurovascular physicians. He also underscores the importance of ethical considerations and humanity in patient care.

Looking ahead, Dr. Kerber advocates for the continued integration of creativity and teamwork in addressing future neurovascular challenges. He closes by offering young physicians advice on embracing imagination and perseverance to drive innovation and improve patient outcomes.

Thank you to Resonetics for sponsoring this episode of Structural Heart Talks. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8

Special thanks to the following for their support in the development of this podcast: Joanna Colangelo, Mark Dickinson, Whitney Garrett, Tracy Murray, SYK, Eytan Raz, MD, Boris Pabon, MD, Joseph Horton, MD, John Barr, MD, and special thanks to William Bank, MD.

Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks to never miss an episode.

Thank you for supporting the Neuro Innovation Talks podcast!

In this episode of the DeviceTalks Weekly podcast, Flow Medical CEO Jennifer Fried tells Host Tom Salemi the story of the MedTech startup that recently closed on a $5 million seed round.

The story checks all the boxes of a great MedTech story.

Physicians Dr. Jonathan Paul and Dr. Osman Ahmed crafted the idea of a new angiography, infusion, and monitoring catheter that could be used to dissolve pulmonary embolism. The napkin drawing grew into a company led by Fried, who had already exited her first startup. Now, with funds in hands, Flow Medical is moving into pre-clinical trials.

Before the interview, Salemi and DeviceTalks Managing Editor Kayleen Brown share news on the expanding DeviceTalks universe including new podcasts, new virtual discussions and a proven way for MedTech companies to tell their stories.

Thank you for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In our final 2024 episode of the DeviceTalks Weekly podcast, ResMed CEO Mick Farrell shares the company’s strategy for reaching the billions of people who need help sleeping, breathing and remaining healthy. He talks with Host Tom Salemi about the company’s connectivity capabilities, response to wearable technology, and its take on a rival’s recall.

This episode is sponsored by Aptyx. Go to www.Aptyx.com to learn more.

We’ll also bring you the Newsmakers of 2024 brought to you by DeviceTalks Managing Editor Kayleen Brown as well as our Editorial Team - Editor Chris Newmarker, Senior Editor Danielle Kirsh, Associate Editor Sean Whooley, and Jim Hammerand, managing editor of Medical Design and Outsourcing.

Thank you for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network on any major podcast player.

In this episode of AbbottTalks, Kartik Sundareswaran, PhD, divisional VP, global clinical and regulatory affairs, Abbott Heart Failure, discusses Abbott’s pioneering work in heart failure care, focusing on technologies that improve outcomes and empower earlier interventions.

Sundareswaran’s path to MedTech began with a shift from computer engineering to biomedical research, where his early work studying blood flow patterns in children with congenital heart disease sparked a passion for solving cardiovascular challenges. This passion led him to roles at Thoratec, St. Jude Medical, and ultimately Abbott, where he has spent years advancing heart failure care.

The conversation highlights Abbott’s CardioMEMS™ Heart Failure System, a device enabling remote pulmonary artery pressure monitoring to reduce hospitalizations, and the HeartMate 3 LVAD, which provides life-extending support for patients with advanced heart failure. Sundareswaran also discusses the new TEAM-HF clinical trial, which combines CardioMEMS and HeartMate 3 to identify patients earlier and deliver timely, effective interventions.

This conversation comes to you courtesy of our episode sponsor, Tecan Group Ltd. To learn more about how Tecan works with medical device companies, visit: https://partnering.tecan.com/

Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.

In this episode of DeviceTalks Weekly, we’ll hear how Perimeter Medical Imaging AI hopes to help surgeons get a clearer picture of whether they removed all cancerous tissue in a surgical procedure. CEO Adrian Mendes explains why 20% of patients who have undergone a lumpectomy must undergo a second operation to remove cancerous tissue that had been missed. Perimeter recently released the positive results from its pivotal study showing it more effectively addressed residual cancer at the surgical margin during surgery as compared to current standard methods. The company is planning to file a PMA with the FDA. Mendes also talks with Host Tom Salemi about his path from the technology industry into running an OCT and AI company targeting oncology.

Perimeter Medical Imaging AI sponsored this episode of the DeviceTalks Weekly Podcast. For more information go to https://perimetermed.com/

MedTech CEO Paul Grand joins Tom and MassDevice Editor Chris Newmarker for this week’s Newmarker’s Newsmakers - Capstan Medical, Cala Health, Anteris Technologies, MedTech M&A and top stories.

Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In this episode of Structural Heart Talks, Todd Brinton, MD, Chief Scientific Officer & CVP, Advanced Technology at Edwards Lifesciences, discusses Edwards’ vision of future innovative technologies that elevate patient care and expand the possibilities of structural heart therapies. Brinton reflects on his journey from biomedical engineering to pioneering roles in MedTech, including his work at Shockwave Medical, and shares how these experiences shaped his mission to create impactful technologies for patients worldwide.

The conversation dives deep into Edwards’ evolving focus on structural heart failure and non-valvular structural heart therapies, emphasizing investigational programs that challenge traditional approaches and push the boundaries of interventional cardiology. Brinton highlights how Edwards fosters a mission-driven culture of collaboration, uniting engineering, clinical expertise, and market insights to tackle some of the most complex challenges in cardiac care.

The episode also underscores the transformative role of mentorship in Brinton’s career and his commitment to paying it forward by empowering others in the MedTech space. Drawing on personal stories, Brinton illustrates how embracing failure and leveraging diverse perspectives have driven innovation at Edwards, paving the way for new therapies that can improve care for patients globally.

* Please note that this episode was recorded before the sale of Edwards’ Critical Care business unit to BD, which closed on Sept 3, 2024.

Thank you to Integer for sponsoring this episode of Structural Heart Talks. To learn more about how Integer supports medical device companies, visit www.Integer.net.

Thank you for listening to the Structural Heart Talks podcast. Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks or the Structural Heart Talks on YouTube Podcasts to ensure you never miss an episode.

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi unpacks the career of Tesh Elavia, vice president of research and development at BD’s surgery division. Elavia’s parents strongly encouraged him to leave his home in India to study in the states. Listeners will hear how he built that uncertain start into a stellar MedTech career.

This episode is sponsored by FPT. Learn more about the company in the podcast or visit FPTsoftware.com

MassDevice Editor Chris Newmarker kicks this off with the Newmarker’s Newsmakers - Edwards Lifesciences, GE Healthcare, Movano Health, Boston Scientific and layoffs in the MedTech Industry.

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.